phosphotyrosine has been researched along with ganglioside, gd2 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bhuiyan, RH; Cheung, NV; Furukawa, K; Hamamura, K; Honke, K; Kambe, M; Kaneko, K; Kotani, N; Ohkawa, Y; Ohmi, Y; Okajima, T; Tajima, O; Yamamoto, S; Yesmin, F; Zhang, P | 1 |
1 other study(ies) available for phosphotyrosine and ganglioside, gd2
Article | Year |
---|---|
Ganglioside GD2 Enhances the Malignant Phenotypes of Melanoma Cells by Cooperating with Integrins.
Topics: Animals; Antibodies, Monoclonal; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Collagen Type I; Gangliosides; Humans; Integrin beta1; Integrins; Mass Spectrometry; Melanoma; Membrane Microdomains; Mice; Phenotype; Phosphotyrosine; Signal Transduction | 2021 |